Previous Close | 0.0432 |
Open | 0.0440 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 0.0425 - 0.0460 |
52 Week Range | 0.0300 - 0.0600 |
Volume | |
Avg. Volume | 260,085 |
Market Cap | 7.093M |
Beta (5Y Monthly) | 0.74 |
PE Ratio (TTM) | 4.59 |
EPS (TTM) | 0.0100 |
Earnings Date | Nov 13, 2023 - Nov 17, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for CVSI
CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, today announced the launch of +PlusCBD™Reserve Collection Sleep Gummies as the brand continues to expand into the sleep aid market.
CV Sciences, Inc. (PNK:CVSI) Q2 2023 Earnings Call Transcript August 14, 2023 Operator: Hello, and welcome to the CV Sciences, Inc. Second Quarter 2023 Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It’s now my pleasure to turn the call over to your host, Brendan Hawkins. Please go ahead. Brendan Hawkins: […]
CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended June 30, 2023.